Miguel Ángel González-Gay

University Name

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (31)

Collaborators (9)

Javier Martin

Instituto de Parasitología y Biomedicina López-Neyra

José Manuel Cifrián‐Martínez

Raquel López-Mejías

Belén Atienza-Mateo

Marqués de Valdecilla University Hospital

Raquel Largo

Solbritt Rantapää Dahlqvist

Umeå Universitet Medicinska fakulteten

F. David Carmona

Associate Professor

Universidad de Granada

Javier Narvaez

Profesor Titular de Medicina

University of Barcelona

Iván Ferraz-Amaro

Universidad de la Laguna

Miguel Ángel González-Gay

Research Interests

Explore related searches

Contact this professor

Articles (31)

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

The Fibrosis-4 Index (FIB-4) correlates with cardiovascular risk and insulin resistance in patients with rheumatoid arthritis

Genome‐wide DNA methylation study reveals specific signatures in the affected arterial tissue of giant cell arteritis patients

Strong correlation between SLEDAI and SLE-DAS in the Spanish population: Assessment of discordant patients

Unmet needs in the management of giant cell arteritis and polymyalgia rheumatica

Performance of four cardiovascular risk scales in chronic inflammatory rheumatic disease patients: 10-year follow-up data

Does genetically determined variation in C-reactive protein affect disease activity assessment in rheumatoid arthritis?

Serum 3-Nitrotyrosine in the Cardiovascular Disease of Patients with Systemic Lupus Erythematosus

Relationship of Serum 3-Nitrotyrosine Levels with Inflammation in Patients with Rheumatoid Arthritis

QRISK3 and SCORE2 are equally reliable predictors of carotid plaques in patients with systemic lupus erythematosus

Osteopontin as a Biomarker in Interstitial Lung Diseases

Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis

Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease

Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients With Rheumatoid Arthritis

Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What—A Critical Review

The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis

Genetics of vasculitis

Effectiveness and Safety of the COVID-19 Vaccine in Patients with Rheumatoid Arthritis in a Real-World Setting

Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis

Relationship of Hematological Profiles with the Serum Complement System in Patients with Systemic Lupus Erythematosus

Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?

E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases

18F-Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography Findings of Polymyalgia Rheumatica in Patients with Giant Cell Arteritis

Lights and shadows on the efficacy of tocilizumab monotherapy in large vessel giant cell arteritis

Malondialdehyde Serum Levels in Patients with Systemic Sclerosis Relate to Dyslipidemia and Low Ventricular Ejection Fraction

HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus

Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients

Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus

Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus

The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis: comment on the article by Yuan et al

Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis